Disease duration and C-peptide at onset are key determinants of long-term residual β-cell function in children with type 1 diabetes

Ganesh Kathirvel, Devi Dayal, Naresh Sachdeva, Mohit Kumar, Savita Verma Attri

Open source

DOI
10.1515/jpem-2026-0474
Published
2026-10-23
Container
Journal of Pediatric Endocrinology and Metabolism
Publisher
Walter de Gruyter GmbH
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1515/jpem-2026-0474,
  title = {Disease duration and C-peptide at onset are key determinants of long-term residual β-cell function in children with type 1 diabetes},
  author = {Ganesh Kathirvel and Devi Dayal and Naresh Sachdeva and Mohit Kumar and Savita Verma Attri},
  year = {2026},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  doi = {10.1515/jpem-2026-0474},
  url = {https://doi.org/10.1515/jpem-2026-0474}
}

RIS

TY  - JOUR
TI  - Disease duration and C-peptide at onset are key determinants of long-term residual β-cell function in children with type 1 diabetes
AU  - Ganesh Kathirvel
AU  - Devi Dayal
AU  - Naresh Sachdeva
AU  - Mohit Kumar
AU  - Savita Verma Attri
PY  - 2026
JO  - Journal of Pediatric Endocrinology and Metabolism
DO  - 10.1515/jpem-2026-0474
UR  - https://doi.org/10.1515/jpem-2026-0474
ER  - 

APA

Kathirvel, G., Dayal, D., Sachdeva, N., Kumar, M., & Attri, S. V. (2026). Disease duration and C-peptide at onset are key determinants of long-term residual β-cell function in children with type 1 diabetes. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2026-0474

Source records